Analyzes the Global Epilepsy Market : Industry Analysis & Outlook 2017-2021 : UCB, EISAI, Pfizer, Sanofi and Lundbeck

ResearchMoz added Latest Research Report titled ” Global Epilepsy Market: Industry Analysis & Outlook (2017-2021) ” to it’s Large Report database.

Epilepsy is a group of neurological diseases characterized by epileptic seizures. Epileptic seizures are episodes that can vary from brief and nearly undetectable to long periods of vigorous shaking. These episodes can result in physical injuries including occasionally broken bones. The medical definition of this disease is as a “condition characterized by recurrent (two or more) epileptic seizures, unprovoked by any immediate identified cause”. Epilepsy is divided into four main types; idiopathic generalized epilepsy, idiopathic partial epilepsy, symptomatic generalized epilepsy and symptomatic partial epilepsy. The cause of epilepsy can be genetic, a result of other disorders such as tumor or brain injury and due to certain seizure triggers.

Epilepsy is treated via antiepileptic drugs, surgery in certain cases and several complementary therapies such as ketogenic diets or neural stimulation. Based upon the drug type, epilepsy market can be divided into three main categories; first generation drugs, second generation drugs and third generation drugs.

Request for Sample PDF of Premium Research Report with TOC:

The global epilepsy market is driven by factors such as development of novel drugs, launch of new drugs in developing regions and prevalence of neural disorders such as meningitis and tumors. This growth is then further spearheaded by increasing healthcare expenses and rising disposable incomes. However, the market growth is hindered by tedious drug approval process, generic erosion and high cost of treatment. Trends such as companies focusing on developing effective therapies for refractory epilepsy and physicians demanding higher efficacy drugs are listed in this report.

The report “Global Epilepsy Drugs Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on the Americas, EMEA and APAC regions. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Novartis AG., Pfizer Inc., GlaxoSmithKline Plc. and UCB are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global epilepsy drugs market along with the study of the regional markets.

Browse more details @

Table of Content

1. Overview
1.1 Epilepsy
1.2 Types of Epilepsy
1.3 Causes
1.5 Treatment
1.6 Epilepsy Market by Drug Class

2. Global Antiepileptic Market
2.1 Global Antiepileptic Drugs Market Forecast by Value
2.2 Global Antiepileptic Drugs Market by Region
2.3 Global Antiepileptic Market by Drug Type
2.3.1 Global Branded Antiepileptic Drugs Market Forecast by Value
2.3.2 Global Generic Antiepileptic Drugs Market Forecast by Value
2.4 Global Branded Antiepileptic Market by Drug Class
2.4.1 Global Second Generation Antiepileptic Drugs Market Forecast by Value
2.4.2 Global Third Gen Branded Antiepileptic Market Forecast by Value
2.4.3 Global First Generation Antiepileptic Drugs Market Forecast by Value

3. Regional Markets
3.1 Americas
3.1.1 Americas Antiepileptic Drugs Market Forecast by Value
3.1.2 The US Antiepileptic Drugs Market Forecast by Value
3.1.3 The US Antiepileptic Drugs Prescription Forecast by Volume
3.1.4 The US Child Epileptic Patients by Volume
3.1.5 The US Child Pharmacoresistant Epilepsy Patient by Volume

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States – 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Follow us on LinkedIn at:
Follow me on Blogger at:

%d bloggers like this: